Breaking News

Poseida Therapeutics Expands Into JLABS

Will foster research collaboration with Janssen for development of allogeneic CAR-T therapies

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Poseida Therapeutics, a privately held human therapeutics spinout of Transposagen Biopharmaceuticals, has begun drug development operations at its new location at JLABS in San Diego, CA. The drug development and license agreement between Transposagen and Janssen, which was announced in November of 2014, has been transferred to Poseida. The three-year drug development partnership and license agreement will focus on developing at least two allogeneic CAR-T product candidates. Poseida will recei...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters